Clinical Trial Update: Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism [Phase 2]

View source ↗

Summary

Phase 2 trial updating clomiphene citrate for obesity-related male hypogonadism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Obesity

Drugs mentioned

• CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)

Snippet

Sponsor: University of Sao Paulo | Conditions: Obesity, Hypoandrogenism | Phase 2 | Status: COMPLETED